Globus Medical, Inc. (GMED)

Globus Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	2,626	2,519	1,568	1,023	958.1	789.04
Revenue Growth (YoY)	17.44%	60.62%	53.34%	6.76%	21.43%	0.47%
Cost of Revenue	863.99	819.88	476.52	262.83	239.22	217.46
Gross Profit	1,762	1,699	1,092	760.01	718.88	571.58
Selling, General & Admin	1,039	977.48	643.41	432.12	408.15	354.76
Research & Development	140.86	161.6	124.01	73.02	97.35	84.52
Operating Expenses	1,299	1,258	818.45	522.87	524.02	456.11
Operating Income	463.84	441.03	273.51	237.15	194.86	115.47
Interest Expense	-	-4.19	-	-	-	-
Interest & Investment Income	2.41	-	20.13	14.23	9.3	13.95
Currency Exchange Gain (Loss)	-22.9	-43.29	14.26	-1.02	-1.42	-0.28
Other Non Operating Income (Expenses)	0.94	1.57	-1.35	7.24	3.36	1.38
EBT Excluding Unusual Items	444.29	395.12	306.55	257.6	206.09	130.53
Merger & Restructuring Charges	-182.04	-274.72	-139.93	-6.85	-16.98	-4.03
Gain (Loss) on Sale of Investments	1.04	0.64	-0.79	-5.39	-2.78	-0.59
Legal Settlements	-0.31	-0.31	-0.43	-2.34	-5.92	-0.01
Other Unusual Items	110.56	-	-	-	-	-
Pretax Income	373.54	120.72	165.39	243.02	180.41	125.9
Income Tax Expense	16.89	17.74	42.52	52.85	31.22	23.61
Net Income	356.65	102.98	122.87	190.17	149.19	102.29
Net Income to Common	356.65	102.98	122.87	190.17	149.19	102.29
Net Income Growth	776.83%	-16.19%	-35.39%	27.47%	45.86%	-34.10%
Shares Outstanding (Basic)	136	136	113	100	101	99
Shares Outstanding (Diluted)	139	138	115	103	104	101
Shares Change (YoY)	4.89%	20.27%	11.68%	-0.95%	2.63%	-1.01%
EPS (Basic)	2.62	0.76	1.09	1.89	1.48	1.04
EPS (Diluted)	2.57	0.75	1.07	1.85	1.44	1.01
EPS Growth	745.36%	-29.91%	-42.16%	28.47%	42.57%	-33.55%
Free Cash Flow	527.43	405.21	165.23	104.42	219.38	135.14
Free Cash Flow Per Share	3.81	2.94	1.44	1.02	2.12	1.34
Gross Margin	67.11%	67.46%	69.62%	74.30%	75.03%	72.44%
Operating Margin	17.66%	17.51%	17.44%	23.18%	20.34%	14.63%
Profit Margin	13.58%	4.09%	7.83%	18.59%	15.57%	12.96%
Free Cash Flow Margin	20.08%	16.08%	10.53%	10.21%	22.90%	17.13%
EBITDA	735.49	695.05	418.24	305.4	264.73	178.35
EBITDA Margin	28.00%	27.59%	26.66%	29.86%	27.63%	22.60%
D&A For EBITDA	271.64	254.02	144.73	68.25	69.87	62.87
EBIT	463.84	441.03	273.51	237.15	194.86	115.47
EBIT Margin	17.66%	17.51%	17.44%	23.18%	20.34%	14.63%
Effective Tax Rate	4.52%	14.69%	25.71%	21.75%	17.30%	18.76%

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q